Gambaran Umum
Exact Sciences Corporation, based in the United States, operates primarily in the diagnostics and research industry focusing significantly on the detection and prevention of cancer. It is renowned for developing Cologuard, an FDA-approved non-invasive stool DNA screening test for colorectal cancer. The company is also expanding its portfolio through innovation and acquisitions, such as its purchase of molecular diagnostics company Genomic Health, enhancing its capabilities in cancer genetics and precision oncology. Additionally, Exact Sciences is advancing in the development of multi-cancer screening technologies that aim to detect various types of cancer from a single blood sample, positioning the company at the forefront of cancer diagnostics research and applications.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Exact Sciences Corporation per 2025 Jun 30 adalah 2,939.95 MM.
- Nilai operating income untuk Exact Sciences Corporation per 2025 Jun 30 adalah -138.98 MM.
- Nilai net income untuk Exact Sciences Corporation per 2025 Jun 30 adalah -1,005.22 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 2,939.95 | -138.98 | -1,005.22 |
2025-03-31 | 2,828.13 | -176.88 | -1,019.84 |
2024-12-31 | 2,758.87 | -191.79 | -1,028.86 |
2024-09-30 | 2,692.33 | -227.22 | -214.04 |
2024-06-30 | 2,612.01 | -282.27 | -175.01 |
2024-03-31 | 2,534.84 | -319.25 | -240.23 |
2023-12-31 | 2,499.77 | -308.83 | -204.15 |
2023-09-30 | 2,405.88 | -346.08 | -282.13 |
2023-06-30 | 2,300.61 | -397.26 | -431.68 |
2023-03-31 | 2,200.16 | -503.21 | -516.72 |
2022-12-31 | 2,084.28 | -634.16 | -623.51 |
2022-09-30 | 2,005.10 | -722.36 | -716.37 |
2022-06-30 | 1,938.40 | -729.34 | -734.55 |
2022-03-31 | 1,851.58 | -709.51 | -745.40 |
2021-12-31 | 1,767.09 | -710.57 | -595.62 |
2021-09-30 | 1,759.61 | -887.92 | -793.35 |
2021-06-30 | 1,711.60 | -749.88 | -828.95 |
2021-03-31 | 1,545.65 | -682.31 | -720.13 |
2020-12-31 | 1,491.39 | -581.70 | -823.61 |
2020-09-30 | 1,320.63 | -200.00 | -327.30 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -5.39.
- laba per saham yang terdilusi untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -5.40.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -5.39 | -5.40 |
2025-03-31 | -5.50 | -5.51 |
2024-12-31 | -5.59 | -5.59 |
2024-09-30 | -1.17 | -1.17 |
2024-06-30 | -0.96 | -0.96 |
2024-03-31 | -1.33 | -1.32 |
2023-12-31 | -1.13 | -1.13 |
2023-09-30 | -1.57 | -1.57 |
2023-06-30 | -2.42 | -2.42 |
2023-03-31 | -2.91 | -2.91 |
2022-12-31 | -3.54 | -3.54 |
2022-09-30 | -4.09 | -4.09 |
2022-06-30 | -4.23 | -4.23 |
2022-03-31 | -4.32 | -4.33 |
2021-12-31 | -3.48 | |
2021-09-30 | -4.74 | -4.74 |
2021-06-30 | -5.12 | -5.12 |
2021-03-31 | -4.60 | -4.60 |
2020-12-31 | -5.45 | |
2020-09-30 | -2.23 | -2.23 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Exact Sciences Corporation per 2025 Jun 30 adalah 305.61 MM.
- Nilai cash from investing activities untuk Exact Sciences Corporation per 2025 Jun 30 adalah 66.87 MM.
- Nilai kas dari aktivitas pendanaan untuk Exact Sciences Corporation per 2025 Jun 30 adalah -250.41 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 305.61 | 66.87 | -250.41 |
2025-03-31 | 323.66 | -305.15 | -21.30 |
2024-12-31 | 210.54 | -442.15 | 231.87 |
2024-09-30 | 233.02 | -467.05 | 231.41 |
2024-06-30 | 118.66 | -418.30 | 231.73 |
2024-03-31 | 112.02 | -204.70 | 23.17 |
2023-12-31 | 156.12 | 49.68 | 159.77 |
2023-09-30 | 138.61 | 58.29 | 159.83 |
2023-06-30 | 73.32 | 156.26 | 159.97 |
2023-03-31 | -88.02 | 111.45 | 207.35 |
2022-12-31 | -223.56 | 74.07 | 76.48 |
2022-09-30 | -300.17 | 210.66 | 54.19 |
2022-06-30 | -300.02 | 96.41 | 54.03 |
2022-03-31 | -198.76 | -719.01 | 3.96 |
2021-12-31 | -102.24 | -1,082.09 | 8.47 |
2021-09-30 | 33.74 | -1,467.16 | 900.53 |
2021-06-30 | 156.29 | -1,401.09 | 904.60 |
2021-03-31 | 109.08 | -613.70 | 907.39 |
2020-12-31 | 136.48 | -702.04 | 1,879.62 |
2020-09-30 | -0.22 | -1,233.53 | 1,006.39 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -9.82.
- p/libro untuk Exact Sciences Corporation pada 2025 Jun 30 adalah 4.18.
- p/tbv untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -10.45.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -9.82 | 4.18 | -10.45 |
2025-03-31 | 3.38 | -8.33 | |
2024-12-31 | 3.24 | -10.18 | |
2024-09-30 | -69.64 | 3.82 | -11.97 |
2024-06-30 | -32.44 | 2.49 | -7.08 |
2024-03-31 | -61.41 | 3.99 | -11.27 |
2023-12-31 | -47.44 | 4.29 | -11.55 |
2023-09-30 | -28.52 | 4.03 | -10.26 |
2023-06-30 | -32.91 | 5.56 | -13.92 |
2023-03-31 | -19.38 | 3.97 | |
2022-12-31 | 2.83 | -7.19 | |
2022-09-30 | 1.79 | -4.86 | |
2022-06-30 | 2.13 | -5.99 | |
2022-03-31 | -20.44 | 3.59 | -11.68 |
2021-12-31 | -16.41 | 3.88 | -15.95 |
2021-09-30 | -19.23 | 4.61 | -21.25 |
2021-06-30 | |||
2021-03-31 | -14.02 | 2.86 | -17.16 |
2020-12-31 | -11.80 | 4.35 | 64.49 |
2020-09-30 | -26.61 | 3.92 | 40.26 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.08.
- EBIT (3 tahun) / EV untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.04.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.08 | -0.04 |
2025-03-31 | -0.10 | -0.06 |
2024-12-31 | -0.02 | -0.03 |
2024-09-30 | -0.01 | -0.03 |
2024-06-30 | -0.02 | -0.05 |
2024-03-31 | -0.01 | -0.04 |
2023-12-31 | -0.02 | -0.05 |
2023-09-30 | -0.03 | -0.05 |
2023-06-30 | -0.03 | -0.04 |
2023-03-31 | -0.04 | -0.06 |
2022-12-31 | -0.07 | -0.07 |
2022-09-30 | -0.10 | -0.10 |
2022-06-30 | -0.08 | -0.08 |
2022-03-31 | -0.06 | -0.05 |
2021-12-31 | -0.07 | -0.05 |
2021-09-30 | -0.06 | -0.03 |
2021-06-30 | ||
2021-03-31 | -0.09 | -0.04 |
2020-12-31 | -0.08 | -0.05 |
2020-09-30 | -0.05 | -0.03 |
Efektivitas Manajemen
- roa untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.15.
- roe untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.32.
- roic untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.20.
- croic untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.00.
- ocroic untuk Exact Sciences Corporation pada 2025 Jun 30 adalah 0.06.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.15 | -0.32 | -0.20 | -0.00 | 0.06 |
2025-03-31 | -0.16 | -0.33 | -0.19 | -0.00 | 0.04 |
2024-12-31 | -0.03 | -0.07 | -0.04 | -0.00 | 0.04 |
2024-09-30 | -0.03 | -0.06 | -0.03 | -0.01 | 0.02 |
2024-06-30 | -0.04 | -0.08 | -0.04 | -0.01 | 0.02 |
2024-03-31 | -0.03 | -0.07 | -0.04 | 0.06 | 0.03 |
2023-12-31 | -0.04 | -0.09 | -0.05 | 0.06 | 0.02 |
2023-09-30 | -0.07 | -0.13 | -0.08 | 0.07 | 0.01 |
2023-06-30 | -0.08 | -0.16 | -0.08 | 0.07 | 0.01 |
2023-03-31 | -0.10 | -0.19 | -0.09 | 0.04 | -0.02 |
2022-12-31 | -0.11 | -0.21 | -0.13 | -0.01 | -0.05 |
2022-09-30 | -0.11 | -0.21 | -0.13 | -0.01 | -0.05 |
2022-06-30 | -0.11 | -0.21 | -0.13 | -0.03 | -0.05 |
2022-03-31 | -0.09 | -0.16 | -0.13 | -0.16 | -0.04 |
2021-12-31 | -0.17 | -0.29 | -0.10 | -0.20 | 0.01 |
2021-09-30 | -0.20 | -0.37 | -0.14 | -0.09 | 0.03 |
2021-06-30 | -0.19 | -0.34 | -0.15 | -0.06 | 0.03 |
2021-03-31 | -0.17 | -0.29 | -0.12 | 0.07 | 0.02 |
2020-12-31 | -0.24 | -0.37 | -0.18 | 0.29 | 0.03 |
2020-09-30 | -0.20 | -0.46 | -0.08 | -0.06 | -0.00 |
Gross Margins
- marjin kotor untuk Exact Sciences Corporation pada 2025 Jun 30 adalah 0.70.
- marjin bersih untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.36.
- marjin operasi untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.07.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.70 | -0.36 | -0.07 |
2025-03-31 | 0.70 | -0.37 | -0.05 |
2024-12-31 | 0.73 | -0.08 | -0.08 |
2024-09-30 | 0.73 | -0.07 | -0.11 |
2024-06-30 | 0.74 | -0.09 | -0.13 |
2024-03-31 | 0.74 | -0.08 | -0.09 |
2023-12-31 | 0.74 | -0.12 | -0.16 |
2023-09-30 | 0.74 | -0.19 | -0.20 |
2023-06-30 | 0.73 | -0.19 | -0.20 |
2023-03-31 | 0.72 | -0.23 | -0.24 |
2022-12-31 | 0.73 | -0.36 | -0.36 |
2022-09-30 | 0.73 | -0.36 | -0.30 |
2022-06-30 | 0.74 | -0.38 | -0.38 |
2022-03-31 | 0.74 | -0.40 | -0.38 |
2021-12-31 | 0.75 | -0.34 | -0.39 |
2021-09-30 | 0.76 | -0.47 | -0.50 |
2021-06-30 | 0.76 | -0.50 | -0.43 |
2021-03-31 | 0.76 | -0.47 | -0.44 |
2020-12-31 | -0.55 | -0.39 | |
2020-09-30 | 0.75 | -0.26 | -0.15 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1124140 |
Grupong Pang-industriya
SIC 8071 - Medical Laboratories |